Wednesday, April 21, 2021
Home Latest Pharma-News FDA Issues Emergency Use Authorization for the Symbiotica COVID-19 Self-Collected Antibody Test...

FDA Issues Emergency Use Authorization for the Symbiotica COVID-19 Self-Collected Antibody Test System

April 06, 2021: The U.S. Food and Drug Administration announced it has issued an emergency use authorization (EUA) for the Symbiotica COVID-19 Self-Collected Antibody Test System, the first antibody test authorized for use with home collected dried blood spot samples.

Samples collected at home are then sent to a Symbiotica, Inc. laboratory for analysis.

- Advertisement -

“The authorization of the first prescription use, home collection antibody test will play an important role in helping health care professionals identify individuals who have developed an adaptive immune response from a recent or prior COVID-19 infection,” said Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health.

“The FDA will continue to authorize COVID-19 tests that will give more Americans access to greater testing flexibility and options.”

The COVID-19 Self-Collected Antibody Test System is authorized for prescription use with a fingerstick dried blood sample that is self-collected by an individual age 18 years or older or collected by an adult from an individual 5 years of age and older. The test is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

The COVID-19 Self-Collected Antibody Test System should not be used to diagnose or exclude acute SARS-CoV-2 infection.

At this time, it is unknown how long antibodies persist following infection and if the presence of antibodies confers protective immunity.

Antibody tests, also known as serology tests, detect antibodies present in the blood when the body is responding to a specific infection, as with SARS-CoV-2.

COVID-19 antibody tests can help identify people who may have had a prior infection or who may have recovered from COVID-19.

However, these tests cannot detect the presence of the SARS-CoV-2 virus to diagnose COVID-19.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.

The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.”

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-symbiotica-covid-19-self

LEAVE A REPLY

Please enter your comment!
Please enter your name here

one × 1 =

Most Popular

Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.

GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures

April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...

JCVI issues new advice on COVID-19 vaccination for pregnant women

April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy.